AS
Aparajita Singh
About Aparajita Singh
Data last updated:
Aparajita Singh is a Director at Jainti Pharmaceuticals Private Limited (since 2020) and Director at Okaneki Private Limited (since 2023). The companies operate in Chemicals and Paper. The largest current company by reported revenue is Jainti Pharmaceuticals Private Limited at ₹1.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jainti Pharmaceuticals Private Limited U24233UP2015PTC074886 | Director | 11 Aug 2020 | 2015 | ₹1.9 Lakh (FY 2025) | Active |
| Okaneki Private Limited U21009HR2023PTC113578 | Director | 24 Jul 2023 | 2023 | Active |
Board colleagues of Aparajita Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jainti Singh | 07322832 | Jainti Pharmaceuticals Private Limited | Director |
| Malvika Singh | 07324426 | Jainti Pharmaceuticals Private Limited | Director |
| Shyam Narain Singh | 07322834 | Jainti Pharmaceuticals Private Limited | Director |
| Mohit Madan | 08326657 | Okaneki Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aparajita Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aparajita Singh
Aparajita Singh currently holds 2 directorships: Jainti Pharmaceuticals Private Limited (Director, since 11 Aug 2020, revenue ₹1.9 Lakh (FY 2025)); Okaneki Private Limited (Director, since 24 Jul 2023).
Aparajita Singh was first appointed on 11 Aug 2020 as Director at Jainti Pharmaceuticals Private Limited. The most recent appointment on record is 24 Jul 2023 at Okaneki Private Limited.
The current boards of Aparajita Singh's companies include Jainti Singh (Jainti Pharmaceuticals Private Limited), Malvika Singh (Jainti Pharmaceuticals Private Limited), Shyam Narain Singh (Jainti Pharmaceuticals Private Limited), Mohit Madan (Okaneki Private Limited).